What is the competitive landscape for PAR PHARM, and when can generic versions of PAR PHARM drugs launch?
has two hundred and twelve approved drugs.
There is one US patent protecting PAR PHARM drugs on PAR PHARM drugs in the past three years. There are fourteen tentative approvals on PAR PHARM drugs.
There are nine patent family members
on PAR PHARM drugs in eight countries and one hundred and seventeen supplementary protection certificates
in twelve countries.